Cancer immunotherapy efficacy is driven by tumour biology, not by its histology. Impact on drug development and approvals. (February 2022)
- Record Type:
- Journal Article
- Title:
- Cancer immunotherapy efficacy is driven by tumour biology, not by its histology. Impact on drug development and approvals. (February 2022)
- Main Title:
- Cancer immunotherapy efficacy is driven by tumour biology, not by its histology. Impact on drug development and approvals
- Authors:
- Bonvalet, Mélodie
Danlos, François-Xavier
Champiat, Stéphane
Rouanne, Mathieu
Marabelle, Aurélien - Abstract:
- Is Part Of:
- European journal of cancer. Volume 162(2022)
- Journal:
- European journal of cancer
- Issue:
- Volume 162(2022)
- Issue Display:
- Volume 162, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 162
- Issue:
- 2022
- Issue Sort Value:
- 2022-0162-2022-0000
- Page Start:
- 130
- Page End:
- 132
- Publication Date:
- 2022-02
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejca.2021.12.004 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 20671.xml